Imagine being able to monitor patients’ mobility and health with the help of small sensors and personalized algorithms – on a daily basis, without them having to come to a clinic regularly and at predetermined intervals. Impossible? Not according to the Innovation in Medicine Initiative (https://www.imi.europa.eu/), who dedicated 25.4 million euro public money to Mobilise-D, matched by 23.6 million euro from EFPIA (European Federation of Pharmaceutical Industries and Associations). Mobilise-D is a pioneering European project that will develop a system using small sensors worn on the body so that how well one walks, a vital sign of health and wellbeing, can be monitored and assessed as one goes about their daily routine.
Mobilise-D will focus on digital mobility assessment being recognized for the analysis and treatment of Chronic Obstructive Pulmonary Disease (COPD), Parkinson’s disease, multiple sclerosis, hip fracture recovery, (Proximal Femoral Fracture, PFF), and congestive heart failure.
The results of Mobilise-D will establish a roadmap for clinical implementation of new, complementary tools to identify, categorize, and monitor disability in patients. This will enable widespread, cost effective access to managing conditions clinically through personalized healthcare.
For more information about the Mobilise-D Project, see our press release here.
